Chain Drug Review

Trade Publishing / Retail Pharmacy Mediachaindrugreview.com

Chain Drug Review is a B2B trade publication and digital media outlet covering the US and Canadian chain drug and retail pharmacy industry, operated by retailmediaIQ in New York with a 1–10 person team serving retailers, wholesalers, and consumer product suppliers via newsletters, digital editions, video, and advertising.

Company typePrivate
Founded-
HeadquartersNew York, United States
Headcount1–10
GTM typeB2B
OfferingDigital Commerce or Content

What Chain Drug Review does

Chain Drug Review (CDR) is a B2B trade publication covering the chain drug and retail pharmacy industry in the United States and Canada, published by retailmediaIQ and headquartered at 33 Irving Place, New York, NY. It serves qualified trade professionals — including drug chains, supermarket chains, discount chains, mass merchandisers, drug wholesalers, warehouse clubs, dollar stores, and e-commerce retailers — through free print and digital subscriptions, while charging manufacturers, schools, libraries, associations, financial institutions, and international subscribers for access. Coverage spans retail news, pharmacy developments, supplier news, research, and industry events, with editorial leadership headed by Editor-in-Chief/VP Jeffrey Woldt and Co-founder/Editorial Director David Pinto.

The publication's core product is a weekly news outlet distributed across multiple channels: a Ghost CMS–powered website, weekly and breaking-news email newsletters (CDR: This Week in Retail and e-NewsBreak), digital editions hosted on Bluetoad, an RSS feed, and a YouTube video program including the Coffee Chat executive interview series. Supporting products include the Women of Influence Awards franchise and the sister publication Mass Market Retailers (MMR), both operated under the retailmediaIQ platform. Advertising is sold through the retailmediaIQ platform, with Google AdSense used as a secondary ad network.

CDR operates with a lean team of 1–10 employees across its New York headquarters and a Skokie, Illinois operations/circulation office. Revenue mechanics rest on a hybrid of qualified-free subscriptions (which build the audience advertisers actually buy), paid subscriptions for non-trade and international readers, and B2B advertising and custom marketing programs aimed at consumer product manufacturers and suppliers seeking reach into retail pharmacy decision-makers. No AI/ML capabilities, public funding, or acquisition activity are disclosed in the source material.

Chain Drug Review firmographics

Firmographics

Name: Chain Drug Review
Legal name: Chain Drug Review
Website: https://chaindrugreview.com
Company type: Private
Operating status: Operating
Headcount range: 1–10 employees
Short description: Chain Drug Review is a B2B trade publication and digital media outlet covering the US and Canadian chain drug and retail pharmacy industry, operated by retailmediaIQ in New York with a 1–10 person team serving retailers, wholesalers, and consumer product suppliers via newsletters, digital editions, video, and advertising.
Ownership category
akta.pro rank

Chain Drug Review industry classification

Industry

Product category: Trade Publishing / Retail Pharmacy Media
NAICS: Health and Personal Care Retailers (456)
SIC: Retail-Drug Stores And Proprietary Stores (5912)
akta.pro primary industry: Business, Finance & Industry Trade Magazines (MPAJAEAM)
akta.pro secondary industry: Discount Drugstores (Value-Focused Chain Pharmacies) (CRAEAHAA)

Keywords

Trade publication
Retail pharmacy news
Chain drug industry
B2B media
Industry newsletters

Where Chain Drug Review is headquartered

Location

Headquarters

HQ city: New York
HQ country: United States
HQ region: North America

Offices2 records

Markets served

Chain Drug Review business model

Business model

GTM type: B2B
Offering type: Digital Commerce or Content
Cost components: Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

Subscription Revenue (Print & Digital): Chain Drug Review offers free subscriptions to qualified subscribers meeting eligibility criteria (individuals employed by retailers within trade classes including drug chains, supermarket chains, discount chains, mass merchandisers, drug wholesalers, warehouse clubs, dollar store chains, and e-commerce retailers). Paid subscriptions are available to manufacturers, schools, libraries, associations, financial institutions, and international orders.
Advertising & Marketing: The publication generates revenue through advertising opportunities targeting the chain drug industry's most influential audience. Marketing programs include digital advertising, print advertising, and custom marketing programs through the retailmediaIQ platform. The site uses Google AdSense for advertising and collects email addresses for marketing communications in compliance with CAN SPAM.
Newsletter Services: Free weekly newsletter 'CDR: This Week in Retail' delivers news and insights. Premium 'Chain Drug Review e-NewsBreak' provides timely news alerts sent directly to inboxes as news happens.

Pricing tiers

Model	Billing	Price
Subscription	Annual	Free Subscription (Qualified Trade Subscribers)
Subscription	Annual	Paid Subscription (Manufacturers, Schools, Libraries, International)

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Chain Drug Review product offering

Product offering

Core offering

Chain Drug Review is a trade publication serving the chain drug and retail pharmacy industry, delivering weekly news, analysis, research, and event coverage through a website, email newsletters, digital editions, and a sister publication Mass Market Retailers. It sells qualified trade subscriptions free to retail industry professionals and paid subscriptions to manufacturers, schools, libraries, and international readers, while monetizing its audience through B2B advertising and custom marketing programs via the retailmediaIQ platform.

Product overview

Chain Drug Review is a retail pharmacy industry publication operated by retailmediaIQ, offering a unified platform of content products. The core offering is the Chain Drug Review publication (print and digital) covering retail news, pharmacy developments, supplier news, and research for the chain drug sector. Supporting products include the Mass Market Retailers (MMR) related publication, email newsletters (CDR: This Week in Retail and e-NewsBreak alerts), and the Women of Influence Awards program. The publisher also offers digital editions archive and provides subscription-based access with free tiers for qualified retail industry professionals.

Differentiator

Problem solved

Functional benefit

Products and services

Chain Drug Review (trade publication) Primary retail pharmacy industry trade publication delivering weekly news, analysis, research, and event coverage to chain drug retailers and pharmacy operators in print and digital formats.
Mass Market Retailers (MMR) Related retail industry trade publication covering mass market and chain retail sectors, operated by the same publisher (retailmediaIQ) and accessible via massmarketretailers.com.
CDR: This Week in Retail (weekly newsletter) Weekly email newsletter delivering news and insights from Chain Drug Review's editorial coverage to retail pharmacy professional subscribers.
Chain Drug Review e-NewsBreak (breaking-news alerts) Timely breaking-news alert service sending Chain Drug Review news directly to subscribers' inboxes throughout the day as news happens.
Digital Editions (archive) Online digital archive of published Chain Drug Review editions hosted on the Bluetoad platform, providing subscribers with multi-year access to past issues and historical industry reference, with three pages of each issue viewable without a subscription.

Companies that use Chain Drug Review

Customer profile

Segments6 records

Ideal customer profiles2 records

Chain Drug Review technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Chain Drug Review partnerships and signals

Strategic signal

Scale indicators2 records

Expansion highlights5 records

Chain Drug Review competitors and assessment

Company assessment

Direct peers

Winsight Grocery Business: Winsight Grocery Business is a B2B trade media brand covering the grocery and convenience retail industries, comparable to Chain Drug Review in audience (retail decision-makers) and adjacent coverage of pharmacy-in-retail topics.
Pharmacy Times: Pharmacy Times is a leading pharmacy trade publication covering pharmacy practice, retail pharmacy operations, and clinical content, directly comparable to Chain Drug Review's pharmacy-focused editorial coverage and B2B audience.
Drug Store News: Drug Store News is the closest direct competitor to Chain Drug Review as a B2B trade publication covering the chain drug and retail pharmacy industry, serving retailers, wholesalers, and suppliers with news, analysis, and event coverage in the same vertical.
Drug Topics: Drug Topics is a pharmacy trade publication serving pharmacists and retail pharmacy professionals with news and clinical content, comparable to Chain Drug Review's coverage of pharmacy operations, prescription access, and automation trends.
Convenience Store News: Convenience Store News is a B2B trade publication covering the convenience retail industry, comparable to Chain Drug Review in its trade-publication business model and overlapping retail-pharmacy-and-wellness category coverage.
Retail Dive: Retail Dive is a digital-first B2B trade publication covering the retail industry including drugstores, supermarkets, and mass merchandisers, directly competing for retail pharmacy decision-maker readership and advertising dollars.
Supermarket News: Supermarket News is a B2B trade publication covering the grocery industry, including supermarket-based pharmacy operations, comparable to Chain Drug Review's coverage of supermarket chains and their pharmacy departments.
Mass Market Retailers: Mass Market Retailers is the sister publication under retailmediaIQ, covering mass-market and chain retail sectors. It is the closest peer by ownership, business model, and editorial format, serving overlapping but distinct retail trade audiences.

Emerging players

Drug Channels: Drug Channels (Drug Channels Institute) is an emerging digital trade media property focused on pharmacy distribution, PBM economics, and retail pharmacy business models, overlapping meaningfully with Chain Drug Review's supplier and pharmacy coverage.

Broad incumbents

NACDS (National Association of Chain Drug Stores): NACDS is the primary trade association for the chain drug industry, providing industry intelligence, policy advocacy, and the Annual Meeting that Chain Drug Review covers. As the dominant industry-governance body, it shapes the editorial agenda and competitive context for trade media peers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Chain Drug Review financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Chain Drug Review leadership team

Management profile

Number of profiles

Profiles6 records

Chain Drug Review funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Chain Drug Review M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chain Drug Review

What does Chain Drug Review do?

Is Chain Drug Review a public or private company?

Chain Drug Review is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Chain Drug Review founded?

Chain Drug Review was founded in -1. It employs 1 to 10 people.

Where is Chain Drug Review based?

Chain Drug Review is headquartered in New York, United States, in the North America region.

How does Chain Drug Review make money?

Three revenue lines are on record. Subscription Revenue (Print & Digital) is the primary driver. The others are advertising & Marketing and newsletter Services.

Who are Chain Drug Review's main competitors?

Direct peers on record are Winsight Grocery Business, Pharmacy Times, Drug Store News, Drug Topics, Convenience Store News, Retail Dive, Supermarket News and Mass Market Retailers. Drug Channels is listed as an emerging player. NACDS (National Association of Chain Drug Stores) is listed as a broad incumbent.

Does Chain Drug Review have an API?

No public API is recorded for Chain Drug Review.

What industry is Chain Drug Review in?

Chain Drug Review's product category is Trade Publishing / Retail Pharmacy Media. Its primary akta.pro industry code is MPAJAEAM, Business, Finance & Industry Trade Magazines, with a secondary code of CRAEAHAA, Discount Drugstores (Value-Focused Chain Pharmacies). Its NAICS code is 456 and its SIC code is 5912.